France: Esteve Healthcare acquires Perrigo’s HRA Pharma Rare Diseases business

Esteve Healthcare, a Barcelona-headquartered global pharmaceutical company, is acquiring Perrigo’s HRA Pharma Rare Diseases business for up to €275m (US$296m), consisting of an upfront cash payment of €190m and up […]